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Abstract
Background: Nasopharyngeal carcinoma (NPC) is a multi-factorial malignancy closely associated with
environmental factors, genetic factors and Epstein-Barr virus infection. Human leukocyte antigen (HLA) complex,
specially the region near HLA-A locus, was regarded as a major candidate region bearing NPC genetic susceptibility
loci in many previous studies including two recent genome-wide association (GWA) studies. To provide further
evidence for the NPC susceptibility in the region near HLA-A locus based on other previous studies, we carried out
a two-stage hospital-based case control association study including 535 sporadic NPC patients and 525 cancer-free
control subjects from Guangdong, a high prevalence area of NPC in China.
Methods: 38 tag SNPs were initially selected by Heploview from the segment around HLA-A locus (from D6S211
to D6S510) and genotyped on GenomeLab SNPstream platform in 206 cases and 180 controls in the stage 1.
Subsequently, the stage 1 significant SNPs and 17 additional SNPs were examined on another platform (Sequenom
iPlex Assay) in another independent set of study population including 329 cases and 345 controls.
Results: Totally eight SNPs from the segment from D6S211 to D6S510 within HLA complex were found to be
significantly associated with NPC. Two of the most significant SNPs (rs9260734 and rs2517716) located near to HLA-
A and HCG9 respectively were in strong LD with some other SNPs of this region reported by two previous GWA
studies. Meanwhile, Meanwhile, novel independent susceptibility loci (rs9404952, Pcombined = 6.6 × 10
-5,O R
combined = 1.45) was found to be close to HLA-G.
Conclusion: Therefore, our present study supports that the segment from D6S211 to D6S510 in HLA complex
region might contain NPC susceptibility loci which indeed needs to be fully investigated in the future.
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Background
Nasopharyngeal carcinoma(NPC)is a sequamous cell
carcinoma that originates from the epithelial lining of
the nasopharynx. The incidence of NPC is low in most
populations around the world but common in the
southern part of China and other Southeast Asia region,
where the incidence can reach 20 to 50 per 100,000
individuals[1,2], suggesting a strong association between
specific genetic factors and NPC. Since 1974, many stu-
dies have indicated that some specific human leukocyte
antigen (HLA) haplotypes and genes within the HLA
complex are potentially associated with NPC [3-5]. Our
previous meta-analysis [3] showed that populations in
geographical areas at higher risk of developing NPC dis-
play HLA distribution patterns different and opposite
from areas of low incidence. HLA complex is undoubt-
edly playing an important role in NPC predisposition,
either by playing a functional role in modulating an
innate and adaptive immune response against EBV, or
as a marker of an unrelated predisposition locus in close
linkage. Using high-resolution microsatellite mapping,
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hypothesized the existence of a NPC susceptibility locus
within a 132 Kb segment (from D6S211 to D6S510)
containing the HLA-A locus in Taiwanese. Recently two
independent research groups [8,9] conducted GWA stu-
dies in Taiwanese and southern Chinese respectively
and consistently strengthened this hypothesis. Therefore,
to further tested the hypothesis and provide further evi-
dence for the possible existence of major susceptibility
of Nasopharyngeal carcinoma in the region near HLA-A
locus, we carried out a two-stage case-control associa-
tion study to focus on the investigation of 132 Kb seg-
ment of interest with moderate sample size (535 cases
and 525 control) in a southern Chinese population.
Materials and methods
Study subjects
This study was approved in advance by the institutional
review Board of Southern Medical University. A total of
535 NPC patients with pathology-based diagnoses and
525 healthy unrelated controls without family or personal
history of cancers and other major illnesses such as
inflammation, diabetes, SLE, rheumatoid arthritis (RA),
etc, were recruited from Jiangmen Center Hospital and
Nanfang Hospital, Guangdong Province, between January
2005 and July 2008. The control individuals were
frequency matched to the NPC cases by age, gender, geo-
graphic region, and ethnicity. Both cases and controls are
of Cantonese origin from Southern China. All participants
were informed by the aim of the study before participating
in the study and required to sign the written informed
consents. Peripheral blood samples were collected from all
the participants and genomic DNA was extracted from
peripheral blood samples using the Tiangen™ Genomic
DNA Kit (Tiangen, China) following to the manufacturer’s
instructions and stored at -80°C before test.
SNP selection, genotyping and quality control
The 132 kb segment between D6S211 and D6S510 (region
from 29903 kb to 30050 kb) is our target region, from
which 100 tag SNPs were selected based on Han Chinese
(CHB) and Japanese (JPT) database in the HapMap Project
[10] by using the Tagger program [11] to capture SNPs
with a minimum minor allele frequency (MAF) of 0.05
and an r
2 of 0.80 or greater.
Of 100 tag SNPs picked out, 38 SNPs with C/T allele,
which may be available for facilitating further DNA
methylation analysis in our another project, were
designed and genotyped for 206 cases and 180 controls
in the first stage, using GenomeLab SNPstream genotyp-
ing platform (Beckman Coulter, Fullerton, California,
USA) as previously described[12]. Subsequently, signifi-
cant SNPs in the first stage, were designed and genotyped
again in the second stage in another set of population
composed of 329 cases and 345 controls, using the
Sequenom iPLEX MassARRAY platform (Sequenom) as
previously described[13]. To further increase the density
of genetic markers, 17 additional SNPs were selected
from those 100 tag SNPs for genotyping as well in the
second stage. In the first stage, a sample call rate of over
95% was observed with 100% matching for quality con-
trol samples and blind replicates. In the second stage, the
DNA sample quality control (QC) threshold was set at
90%.
Statistical analysis
Deviations from the Hardy-Weinberg equilibrium (HWE)
were firstly assessed using the Fisher’s exact test or the
Chi-square test. SNPs with HWE test p value > 10
-3 could
be underwent further calculation. Association analysis
based on unconditional logistic regression was carried out
by figuring the odds ratio (OR) and 95% confidence inter-
val (95% CI) for tag SNPs. The significance level was set at
0.05. All calculations were done with SPSS 13.0 software
(SPSS, Chicago, IL).
The linkage disequilibrium (LD) and haplotype block
analysis between significant SNPs in this study and other
published SNPs located in HLA region (Additional file 1:
Table S1) were calculated by Haploview software 4.2 using
Han Chinese (CHB) and Japanese(JPT) data presented in
the HapMap Project http://www.hapmap.org. D’ and r
2
were used to describe LD relationship. The confidence
interval method was adopted to set the haplotype block.
This algorithm was taken from Gabriel et al. [14], in
which 95% confidence bounds on D’ were generated and
each comparison was labeled “strong LD” (linkage disequi-
librium), “inconclusive,” or “strong recombination”.
Results
Demographic characteristics of both NPC cases and can-
cer-free controls were presented in Additional file 2: Table
S2. Briefly, there was no significant difference in the distri-
bution of age (P = 0.904) and gender (P = 0.874) between
the cases and the controls. Among 535 NPC cases, 470
were Poorly differentiated SCC ( Squamous cell carci-
noma), 58 Undifferentiated cancer, 7 Differentiated SCC.
Both cases and controls are of Cantonese origin from
Southern China.
A total of 38 tag SNPs included in the first stage were
successfully genotyped. However, of them, five (rs1611650,
rs9295822, rs9260759, rs1611442 and rs6457116) were
found to have minor allele frequencies (MAFs) of less
than 5%, and other two SNPs (Rs3202637 and rs2517681)
were found to deviate from HWE. Therefore, the remain-
ing 31 SNPs were further analyzed for genotype and allele
frequencies.
As shown in Table 1 there were five SNPs (rs2517716,
rs3869062, rs9260734, rs9260475 and rs9404952)
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SNP Position Nearest Alleles
a Stage I
e Stage II
f Combined
g
Gene MAF(%)
b P
c OR(95%CI)
d MAF(%)
b P
c OR(95%CI)
d MAF(%)
b P
c OR(95%CI)
d
rs2517716 30025239 HLA-A A/G 35.43 3 × 10
-3 1.772(1.214-2.586) 39.6 4 × 10
-3 1.420(1.120-1.800) 38.3 5.9 × 10
-7 1.62(1.34-1.95)
rs9260734 30040645 HCG9 G/A 30.06 2 × 10
-3 1.845(1.258-2.705) 32.8 4 × 10
-4 1.535(1.209-1.95) 31.9 3.3 × 10
-7 1.67(1.37-2.03)
rs9404952 29912144 HLA-G A/G 34.86 1.7 × 10
-2 1.528(1.080-2.163) 37.7 3 × 10
-3 1.419(1.13-1.782) 36.7 6.6 × 10
-5 1.45(1.21-1.75)
rs3869062
- 30042870 HCG9 A/G 27.71 1.8 × 10
-2 1.58(1.082-2.308)
rs9260475
※ 30028105 HLA-A T/C 37.57 1 × 10
-4 2.034(1.426-2.902)
a Major/minor alleles as determined by allele frequency among genotyped controls;
b Minor allele frequency among genotyped controls;
c, d OR, odds ratio for major allele, adjusted by logistic regression for gender
and age;
e Stage 1, n = 206 cases and 180 controls;
f stage 2, n = 329 cases and 345 controls;
g combined stage 1 and 2, n = 535 cases and 525 controls. In stage 2, variations with
- call rate < 90% and
※ HWE <
0.001 were omitted.
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7showed significant differences in genotype and allele fre-
quency adjusted for age and gender between NPC case
and control group in the first stage. Although rs9260475
was unfortunately excluded as it was not in HWE, and
rs3869062 showed a lower call rate (less than 90%) in
the second stage, rs2517716, rs9260734 and rs9404952
still remained significant. Combination of these variant
genotypes of stage 1 and stage 2 clearly showed that
rs2517716 (OR combined = 1.62, P combined = 5.9 × 10-7),
rs9260734 (OR combined = 1.67, P combined = 3.3 × 10-7),
and rs9404952 (OR combined = 1.45, P combined =6 . 6×
10-5) were associated with a significantly increased risk
of NPC.
Interestedly, rs9260734 has been previously reported
to be associated with NPC risk in two GWA studies
[8,9], but it was using less tag SNPs in a relatively small
sample population that we could still detect its associa-
tion effect. Moreover, rs9260734 and rs2517716 were
found to map to a 35 kb region containing HCG9 and
HLA-A (Table 1 Figure 1). For further confirming our
result, we picked out 17 additional SNPs from this
region for subsequent analysis. Of them, five (rs1632882,
rs2571400, rs2735085, rs1632902 and rs16896742) dis-
played statistical significance (Additional file 3: Table
S3) as well, strongly indicating the possible existence of
candidate NPC susceptibility in this region.
Furthermore, the linkage disequilibrium (LD) analysis
was performed according to HapMap CHB and JPT
data to measure LD for significant SNPs in our data set
vs. significant SNPs in HLA complex from two recent
GWA studies (Additional file 1: Table S1). Three LD
blocks were formed separately (Figure 2). Some of sig-
nificant SNPs were assigned into separate LD blocks
together with some significant SNPs reported by Taiwan
GWAS (rs2517713 and rs2975042) and the southern
Chinese GWAS (rs2860580). Rs2517716 was in high LD
with rs2517713 in block 2(D’ =1 ,r
2 = 0.7). Rs1632882,
rs16896742 and rs2735085 of 17 additional SNPs and
two GWAS rs2860580 and rs2975042 formed block 1
and 3. The LD coefficient D’ was 1 and r
2 was 0.631
between rs2860580 and rs1632882. The LD coefficients
(D’)r a n g e df r o m0 . 9 5 2t o1a n dr
2 value ranged from
0.223 to 0.56 between rs2975042, rs16896742 and
rs2735085. Therefore, although some of our significant
loci were inconsistent with previous GWA studies, our
LD analysis displayed strong LD relationships between
them.
Rs9404952 as a novel SNP was located at another
region downstream from HLA-G which has never been
reported to be associated with NPC before. Accordingly,
Rs9404952 did not merge with any blocks and the D’
and r
2 between it and other SNPs were very low (D’
from 0.006 to 0.676, r
2 from 0 to 0.271), suggesting that
it might be an independent susceptibility factor.
Discussion
Applying a two stage case-control analysis in southern
Chinese, we demonstrated that multiple loci within the
29903kb                                           35kb    30060kb
rs2517716   
rs9260734
rs9404952      
HLA-G                                        HLA-A          HCG9       
Figure 1 Genotype association mapping in the region between D6S211 and D6S510. The X-axis represents the locus of each SNP and the
Y-axis represents the corresponding -Log10 (P-value) for each SNP locus. Two significant SNPs in black frame were omitted in the second stage.
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ciated with NPC susceptibility in consistence with pre-
vious findings [6-9,15]; rs2517716 near HLA-A and
rs9260734 near HCG9 were found significant, and a
novel significant SNP, rs9404952, was close to the HLA-
G gene suggesting HLA-G might be a new susceptible
locus for NPC, and needs to be further researched.
T h eH L A - Ag e n ei saH L Ac l a s sIg e n e ,w h i c hi s
involved in the presentation of foreign peptide antigens
including EBV-derived peptides. HCG9 belongs to a
multigene family (HCG) and is believed to be non-cod-
ing, but its function has not been determined. HLA-A
and HCG9 were reportedly associated with the develop-
ment of EBV-associated Hodgkin lymphoma [16] and
infectious mononucleosis (IM) after primary EBV infec-
tion [17]. The association of HLA-A and HCG9 poly-
morphisms with NPC was reported in numerous studies
including two GWA studies [6-9]. In addition, a recent
association study was carried out by Li Y [15] validating
Taiwan’s GWAS and presenting three NPC susceptible
SNPs, of which two located at HLA-A and HCG9 loci.
In the current study, we found several NPC-associated
risk SNPs near HLA-A and HCG9 locus as well.
Interestedly, rs2517716 as one of the most significant
SNPs was closed to the HLA-A locus and genetically
linked to rs2517713 reported significant in the Taiwan
group(r
2 = 0.7 and D = 1)based on Han Chinese (CHB)
and Japanese (JPT) ancestries from HapMap data.
Rs9260734 near HCG9 had been reported by both
GWA studies in Taiwanese and Southern Chinese
respectively [8,9], and also confirmed in the present
study though it seems that its association signal might
originate from the effects of HLA-A according to a pre-
vious research [9].
Moreover, in addition of the HLA-A and HCG9, our
d a t af o rt h ef i r s tt i m es h o w e dt h a tH L A - Gm i g h tb e
involved in NPC susceptibility in southern Chinese.
HLA-G belongs to the HLA non-classical class I heavy
chain paralogues and seems to play a crucial role in
immuno-tolerance mechanisms [18]. More recently,
some studies have suggested that HLA-G plays an impor-
tant role through the immune system in tumor develop-
ment and progression [19-23]. It possesses the ability to
suppress immune cell functions, such as NK- and CTL-
mediated cytolysis and T-cell proliferative progress.
HLA-G expression has been identified in several tumors
Figure 2 LD between significant SNPs from our case-control study and other Significant SNPs from two NPC GWA studies based on
CHB and JPT HapMap data. LD was measured as D’. The red squares represent the LD between the two loci; the redder the color, the greater
the linkage disequilibrium. Red cell without a number reflects D’ = 1. Loci significant in the present study were marked in red frame in three
blocks which were marked in black frame.
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lymphoma, and renal and lung cancers [19-23]. Ghandri
N et al. [24] examined HLA-G gene polymorphisms in
NPC for the first time using the restriction fragment
length polymorphism-polymerase chain reaction (RFLP-
PCR) and the amplification refractory mutation system-
polymerase chain reaction (ARMS-PCR) method in
Tunisian and found three nonsynonymous SNPs in
codons not to associate with NPC susceptibility but
implicate in NPC progression and survival. In the present
study, rs9404952 located downstream of HLA-G gene
showed a significant association with NPC though a less
significant difference was found in the stage 1 (P = 0.017)
possibly due to its small sample size. Hence, HLA-G
might be a previously unreported candidate susceptibility
locus for NPC among southern Chinese.
It is noted that previous GWA studies could not find
the association of rs9404952 with NPC after scanning the
whole human genome. The possible reasons are inferred
as follow. First, due to its relatively larger P value (e.g., P
>1 0
-5) in the preliminary stage of GWA studies, this
SNP might be omitted from bioinformatics analysis. Sec-
ond, such deviation might be resulted from genetic het-
erogeneity between populations. Furthermore, perhaps
this SNP was not successfully genotyped by the genome-
wide SNP-typing arrays due to some unclear reasons.
Conclusion
In this study, we utilized tag SNPs according to Hapmap
database to target the 132 kb segment between D6S211
and D6S510, and identified several loci significantly
associated with NPC. In contrast to the GWA studies
that examined large sample sets and more than thou-
sands of genetic markers, our case-control analysis
employed less tag SNPs in relatively small samples.
Interestedly, we could also detect significant polymorph-
isms in HLA-A and HCG9, and even identified a new
candidate susceptibility locus near HLA-G. Our study
supported that the some HLA loci indeed have strong
genetic effect for NPC.
Therefore, further investigations should be done in the
future to expand the search for NPC susceptibility loci
within or close to the HLA region, to explore functional
loci depended on more advanced means, such as tar-
geted exomic sequencing, and to further investigate the
association between HLA-G locus and NPC risk.
Additional material
Additional file 1: Table 1Significant loci within HLA-A region
identified by previous GWAS.
Additional file 2: Table 2 Distributions of select characteristics
among patients and controls. SCC: Squamous cell carcinoma. * Two-
sided c
2 test.
Additional file 3: Table 3 Additional significant SNPs identified
through the second stage.
a Major/minor alleles as determined by
allele frequency among genotyped controls;
b Minor allele frequency
among genotyped controls;
c, d OR, odds ratio for major allele, adjusted
by logistic regression for gender and age.
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